NCT04833205 2021-04-20Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung CancerHebei Medical UniversityPhase 2 Unknown30 enrolled